The identification of both gain- and loss-of-function mutations of PRC2 in cancer may indicate that a critical balance of polycomb activity is essential for cellular homeostasis, with either loss or gain of PRC function being potentially tumorigenic. This evidence concerns the gene PPRC1 and cancer.